Orionis Biosciences LLC — Form D
Orionis Biosciences LLC of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-03. The offering totals $25.5M, of which $19.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-04-03
- Form: D
- Accession: 0001654107-18-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.5M
- Amount sold: $19.7M
- Remaining: $5.8M
- Investors: 9
- Date of first sale: 2018-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-309162
Issuer
- Name: Orionis Biosciences LLC
- CIK: 0001654107
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 275 GROVE STREET, NEWTON, MA, 02466
- Phone: 617-663-4882
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Steven R Gullans, Ph.D. | Director | Newton, MA |
| Nikolai Kley, Ph.D. | Director | Newton, MA |
| Griet R Vanpoucke, Ph.D. | Director | Newton, MA |
| Nikolai Kley, Ph.D. | Executive Officer | Newton, MA |
Other filings by this issuer (2)
More